RICC A/S: Financial statements 2018
CVR: 20690003
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
RICC A/S (CVR 20690003) has filed annual accounts for 2018. In 2018, the company reported revenue of DKK 198,621,000 and a net result of DKK 914,000 compared with DKK 38,263,000 the year before. The profit margin was 0.5%. Equity in the 2018 report amounted to DKK 107,002,000. The solvency ratio was 55.2%. The company had 74 employees in the financial year.
- Revenue
- DKK 198,621,000
- Gross Profit
- DKK 159,341,000
- Profit/Loss
- DKK 914,000
- Equity
- DKK 107,002,000
- Total Assets
- DKK 193,900,000
- Employees
- 74
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | 198.6 mio. | 159.3 mio. | 914 t. | 107 mio. | 74 |
| 2017 | - | 175.8 mio. | 38.3 mio. | 156.1 mio. | 71 |
| 2016 | - | 134.6 mio. | 66.3 mio. | 197.8 mio. | 68 |
| 2015 | - | 174.3 mio. | 1.2 mia. | 211.5 mio. | - |
| 2014 | - | 138.2 mio. | -5.5 mio. | -68 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of September 11, 2018, Sylke Pöhling has joined the board of directors of RICC A/S.
As of September 11, 2018, Pearl Shirley Huang has left the board of directors of RICC A/S.
RICC A/S has published its annual report for 2017. Gross profit came to DKK 175,825,000, and the net result was DKK 38,263,000.
As of April 24, 2018, Richard John Wright is registered as director of RICC A/S.
As of April 24, 2018, Jens Bo Rode Hansen has stepped down as director of RICC A/S.
As of April 23, 2018, Pearl Shirley Huang has joined the board of directors of RICC A/S.
As of April 23, 2018, Jens Bo Rode Hansen has left the board of directors of RICC A/S.
As of April 2, 2018, John Christian Reed has left the board of directors of RICC A/S.
About RICC A/S
RICC A/S is a Danish company of the type Aktieselskab based in København V, founded in 1998. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ROCHE INNOVATION CENTER COPENHAGEN A/S and SANTARIS PHARMA A/S. The management consists of Carole Hassoun. The board consists of Sylke Pöhling (chair), Carole Hassoun and Isabel Marianne Joerin. The company is owned by F. Hoffmann-La Roche Ltd. The company has 1 employee (2024). In 2025, the company reported a gross profit of DKK 91,000 and a net result of DKK 160,586,000 compared with DKK 730,000 the year before. Equity in the 2025 report amounted to DKK 163,015,000.